Introducing: Conversations on Commercialization

About this episode

The episode introduces a new spinoff podcast focusing on commercialization decisions in biopharma.

Commercialization decisions are shaping success earlier than ever in the product lifecycle, from value and access to launch strategy, deployment and stakeholder engagement. Conversations on Commercialization, a new spinoff of the Syneos Health Podcast, explores what this shift means for biopharma companies and what it takes to compete in a rapidly evolving market. Led by Tyler Cowan, Commercial Vice President at Syneos Health, and joined by a bench of expert co-hosts, the podcast brings...

People in this episode

Host: Tyler Cowan

Topics covered

• commercialization
• biopharma
• product lifecycle
• launch strategy
• stakeholder engagement

Keywords

• commercialization
• biopharma
• product lifecycle
• launch strategy
• stakeholder engagement

Mentioned in this episode

Organizations: Syneos Health, biopharma companies

More episodes of The Syneos Health Podcast

• Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale · May 29, 2026 · 16 min
• Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner · May 22, 2026 · 25 min
• Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role · May 11, 2026 · 25 min
• Site Realities Series | Inside the Site Experience: Challenges, Tradeoffs and Opportunities · May 1, 2026 · 40 min
• Conversations on Commercialization: Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US · February 19, 2026 · 23 min
• Functionally Speaking Series: Regulatory Intelligence, Medical Writing and the AI Inflection Point · January 30, 2026 · 37 min